Cepharanthine
Latest Information Update: 27 Nov 2006
Price :
$50 *
At a glance
- Originator Kaken Pharmaceutical
- Class Alkaloids; Anti-infectives; Antineoplastics; Nonsteroidal anti-inflammatories
- Mechanism of Action Apoptosis stimulants; HIV replication inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; HIV-1 infections